Table 2 Differences in gametocyte carriage before and after SMC treatment
Measure | Group | p value | |
|---|---|---|---|
SMC | Comparison | ||
Percentage of gametocyte carriers before SMC treatment | 7/65 (10.7%) | 10/75 (13.3%) | 0.64* |
Percentage of gametocyte carriers after SMC treatment | |||
Received at least first dose of treatment | 5/53 (9.4%) | 9/71 (12.7%) | 0.57* |
Received all 3-day doses of treatment | 5/32 (15.6%) | 9/71 (12.7%) | 0.68* |
Odds ratio comparing gametocyte carriage before vs after SMC treatment. OR (95% CI) | |||
Received at least first dose of treatment | 0.6 (0.14–2.51) | 0.48∞ | |
Received all 3-day doses of treatment | 1.0 (0.20–4.95) | 1.00∞ | |
0.9 (0.34–2.30) | 0.80∞ | ||